Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
2.360
-0.100 (-4.07%)
At close: Jun 16, 2026, 4:00 PM EDT
2.390
+0.030 (1.27%)
After-hours: Jun 16, 2026, 7:56 PM EDT
Editas Medicine Market Cap
Editas Medicine has a market cap or net worth of $362.17 million as of June 16, 2026. Its market cap has increased by 144.43% in one year.
Market Cap
362.17M
Enterprise Value
255.82M
1-Year Change
144.43%
Ranking
Category
Stock Price
$2.36
Market Cap Chart
Since February 3, 2016, Editas Medicine's market cap has decreased from $620.67M to $362.17M, a decrease of -41.65%. That is a compound annual growth rate of -5.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 360.64M | 80.21% |
| Dec 31, 2025 | 200.12M | 90.89% |
| Dec 31, 2024 | 104.84M | -87.33% |
| Dec 29, 2023 | 827.35M | 38.68% |
| Dec 30, 2022 | 596.59M | -66.78% |
| Dec 31, 2021 | 1.80B | -58.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sagimet Biosciences | 399.53M |
| Autolus Therapeutics | 399.21M |
| Benitec Biopharma | 389.23M |
| X4 Pharmaceuticals | 384.82M |
| Larimar Therapeutics | 374.73M |
| Compass Therapeutics | 367.38M |
| REGENXBIO | 365.50M |
| Lexeo Therapeutics | 365.13M |